Hemostasis & Tissue Sealing Agents Market Growth, Share, Size, Trends and Forecast 2025

                                                                            
Hemostats, as well as adhesives and sealants, are essential components of current surgical techniques.

Hemostasis & Tissue Sealing Agents Market


Hemostats, as well as adhesives and sealants, are essential components of current surgical techniques. Topical hemostats are utilised primarily intraoperatively and to a lesser extent afterwards. Raw surface bleeding, oozing venous type bleeds, bone bleeding, and needle-opening bleeding can all be treated with these products.

As a consequence of factors such as a growth in the number of surgical procedures and a rise in the number of traffic accidents, the global hemostasis and tissue sealing agents market is expected to grow significantly. Surgery is one of the most popular treatments delivered by the NHS in the United Kingdom, with 4.7 million admissions across a variety of locations, according to the Health and Social Care Information Centre (HSCIC). The data also shows that the number of surgical operations increased by 27% between 2004 and 2014. Approximately 200,000 persons died in the United States in 2014 as a consequence of trauma injuries, according to the Centers for Disease Control and Prevention (CDC).

According to the American Joint Replacement Registry's (AJRR) annual report for 2016, a total of 427,181 joint replacement surgeries were documented. However, market expansion is likely to be hampered by a lack of favourable reimbursement policies for hemostat failure in blood loss management, as well as rising surgical treatment costs.


Market Segmentation:

By Product Type:
  • Topical Hemostats
  • Adhesives & Tissue Sealing Agents

By End User:
  • Hospitals
  • Ambulatory Surgical Centers
  • Home Care Settings

The key players operating the global hemostasis & tissue sealing agents market include Cryolife, Inc. Baxter International, Inc., Ethicon LLC, Integra Lifesciences Corporation, Becton, Dickinson & Company, Cohera Medical, Inc., Pfizer, Inc., Medtronic plc, B. Braun Melsungen AG, MIL Laboratories Pvt. Ltd, Advanced Medical Solutions Group Plc, and others.

Comments

Post a Comment

Popular posts from this blog

Flavors and Fragrances Market: A Comprehensive Analysis of Current Trends and Future Outlook

Image
  Flavors and Fragrances Market Introduction: The global flavors and fragrances market has witnessed remarkable growth in recent years, driven by increasing consumer preferences for enhanced sensory experiences in various industries. Flavors and fragrances play a vital role in food and beverages, personal care products, household products, and the pharmaceutical industry. This report provides an in-depth analysis of the flavors and fragrances market, highlighting key trends, market dynamics, and future prospects. Market Overview: The flavors and fragrances market has experienced substantial growth, with a projected CAGR of X% from 2023 to 2028. The market is primarily driven by rising disposable incomes, urbanization, and changing consumer lifestyles. Key market players are continually investing in research and development activities to introduce innovative flavors and fragrances that cater to evolving consumer demands. Segmentation and Key Market Players: The market can...
Read more

Exploring the Different Types of Blood Clotting Factors and Their Functions

Image
  Blood Clotting Factor Coagulation, another name for blood clotting, is a complicated process that is essential for reducing excessive bleeding after an injury. It entails a chain of events that cause a blood clot to develop, sealing the injured blood artery and stopping further bleeding. Blood clotting factors are a group of proteins that control these processes. Roman numerals from I to XIII are used to identify each of the 13 distinct blood clotting factors. The liver makes them, and platelets, the tiny blood cells that aid in blood clotting, also make some of them. Each of these elements interacts with the others in a series of reactions, activating the one before it. Factor I : Also known as fibrinogen, is a protein that is converted into fibrin, the main component of a blood clot. Factor II, also known as prothrombin, is converted into thrombin, which converts fibrinogen into fibrin. Factor III, also known as tissue factor, is released by damaged tissue and initiates the...
Read more

Global Orthopedic Imaging Market Size By Product, By Indication, By End User, Analysis And Forecast 2027

Image
                              Orthopedic Imaging Market Medical imaging in orthopaedics allows doctors to examine the interior architecture of the body non-invasively to aid in the diagnosis of a medical disease. Medical imaging technologies detect and track illnesses and injuries by providing pictures that represent the interior anatomical features of the patient's body. These gadgets are utilised as a knowledge tool to assist clinicians in determining the condition and its response to therapy. Orthopedic medical imaging provides clinicians with dependable, accessible, and high-quality imaging, which is an important criterion for medical decision-making and may lessen the need for surgical operations. Increased incidences of bone fracture trauma due to falls, motor vehicle accidents, or sports injuries necessitate prompt medical attention, which orthopaedic medical imaging systems may deliver. According to the ...
Read more